Point of Care Ultrasound for the Detection of Esophageal Food Bolus

July 11, 2024 updated by: Brent Becker, WellSpan Health

This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.

Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.

Study Overview

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • York, Pennsylvania, United States, 17403
        • Recruiting
        • Wellspan Health York Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This will be a case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. We will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.

Description

Eligibility (CASES)

  • Inclusion criteria:

    1. Age ≥18 years
    2. Signs and symptoms of esophageal food bolus or foreign body
  • Exclusion criteria:

    1. Prior esophageal surgery
    2. History of head/neck cancer
    3. Incarcerated individuals
    4. Individuals unable to provide consent
    5. Clinical instability or airway compromise

Eligibility (CONTROLS)

  • Inclusion criteria:

    1. Age ≥18 years
    2. NO signs or symptoms of esophageal food bolus or foreign body
    3. Age/Sex match to previously enrolled case subject
  • Exclusion criteria:

    1. Prior esophageal surgery/dilation/pathology
    2. History of head/neck cancer
    3. Incarcerated individuals
    4. Individuals unable to provide consent
    5. Clinical instability or airway compromise
    6. Presentation involving any of the following symptoms:
  • Nausea/vomiting
  • Diarrhea
  • Abdominal pain
  • Chest pain
  • Shortness of breath
  • Dysphagia/odynophagia
  • Cough

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Esophageal foreign body/impaction (suspected)

Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:

  • Presence/absence of suspected foreign body
  • Sonographic esophageal measurements (diameters, area)
  • Other relevant secondary sonographic findings
Control (No symptoms of esophageal foreign body/impaction)

Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:

  • Presence/absence of suspected foreign body
  • Sonographic esophageal measurements (diameters, area)
  • Other relevant secondary sonographic findings

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence or absence of esophageal foreign body/food impaction
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
Presence of absence of esophageal foreign body/food impaction on esophagogastroduodenoscopy
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies, including glucagon and carbonated beverages
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
Number/proportion of subjects requiring endoscopic intervention
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
Number/proportion of subjects needing interventional procedures during esophagogastroduodenoscopy due to esophageal symptoms
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

July 5, 2024

First Submitted That Met QC Criteria

July 11, 2024

First Posted (Actual)

July 18, 2024

Study Record Updates

Last Update Posted (Actual)

July 18, 2024

Last Update Submitted That Met QC Criteria

July 11, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2207289

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Esophageal Obstruction

Clinical Trials on Point of care ultrasound

Subscribe